– USA, CA – SamaCare, a prior authorization platform for physician-administered medications, today announced the addition of Dr. Arif Nathoo (M.D.) CEO and co-founder of Komodo Health, to its Board of Directors.
About Dr. Arif Nathoo
Dr. Arif Nathoo currently serves as CEO of Komodo Health, a leading healthcare analytics company that helps providers, researchers, and patient advocates better leverage clinical data to improve large-scale health outcomes. Before founding Komodo in 2014, Nathoo was a leader in the Medical Affairs practice at McKinsey & Company.
About SamaCare
SamaCare helps pharmaceutical companies, providers, and other stakeholders get life-changing therapies for patients needing them. It provides a free workflow automation platform for medical practices to streamline administrative processes, such as prior authorization of specialty drugs. On top of that free platform, SamaCare delivers premium services and data for pharmaceutical brands to improve access to therapy. SamaCare currently works with retina, oncology, neurology, and rheumatology practices that account for tens of billions of dollars in annual specialty drug spend and continues to grow quickly.
SamaCare is committed to improving the healthcare experience for patients and providers alike through the use of technology and data analytics. Over 7,700 providers and some of the largest pharmaceutical manufacturers in the world take advantage of SamaCare’s portal to unify the submission, tracking, and management of prior authorizations across all payers and plans for buy-and-bill medications.
For more information: https://www.samacare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.